APA (7th ed.) Citation

J, R. C., SN, J., R, S., WP, Y., M, L., Y, H., . . . DSP, T. (2025). NEXUS: A phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies. Therapeutic advances in medical oncology, 17, 17588359251339930. https://doi.org/10.1177/17588359251339930

Chicago Style (17th ed.) Citation

J, R Choo, et al. "NEXUS: A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Asian Patients with Advanced/metastatic Solid Malignancies." Therapeutic Advances in Medical Oncology 17 (2025): 17588359251339930. https://doi.org/10.1177/17588359251339930.

MLA (9th ed.) Citation

J, R Choo, et al. "NEXUS: A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Asian Patients with Advanced/metastatic Solid Malignancies." Therapeutic Advances in Medical Oncology, vol. 17, 2025, p. 17588359251339930, https://doi.org/10.1177/17588359251339930.